``Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders Drug Pipeline Report'' Contains Detailed Information on the Current Drug Pipeline
Posted on: Monday, 16 July 2007, 06:08 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c62772) has announced the addition of "Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders Drug Pipeline Report" to their offering.
"Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of hemophilia or blood coagulation disorders drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
-- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
-- Keep track of your competitors and partners by better understanding their product pipeline.
-- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
-- Maintain a critical competitive advantage.
Hemophilia or Blood Coagulation Disorders Pipeline Overview
-- % of Projects (By Phase of Development)
-- No. of Projects by Phase of Development
-- Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
-- Company Overview - Pipeline Projects
-- Legend
-- Top 20 companies in late stage Hemophilia or Blood Coagulation Disorders Projects
-- Top 20 companies in early stage Hemophilia or Blood Coagulation Disorders Projects
Full Pipeline View
-- Pre Clinical Pipeline View
-- Phase I Pipeline View
For more information, visit http://www.researchandmarkets.com/reports/c62772.
Source: Life Science Analytics
Source: Business Wire
Related Articles
- First Uranium Provides Production and Project Development Update for the First Fiscal Quarter Ended June 30, 2008
- Learn About Key Pipeline Products That Are Set to Shape the Market With United States In Vitro Diagnostics Industry Report
- The Global Market for Angiogenesis Therapeutic Products is Projected to Reach About US$ 22 Billion By 2012
- PSTS China to Commence Production Expansion Project
- Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders
- University of Maryland Announces 28 Research Projects to Help Maryland Companies Develop Commercial Products: Projects Worth $5.2 Million
- Medistem Laboratories Announces Plan for Angiostem(TM) to Be First Pipeline Product for U.S. Commercialization
- Cell Genesys Announces Publication of Encouraging Phase 1/2 Clinical Results For GVAX(R) Immunotherapy for Prostate Cancer in Early Stage Patients Before Receiving Hormone Therapy
- Clinical Data on Pharmion's Marketed and Pipeline Products to Be Presented at the American Society of Clinical Oncology 42nd Annual Meeting
- Wave Systems' Secure Enterprise Software and Server Products to Be Demonstrated at the Intel Developer Forum, Booth 943, August 23-25, Moscone Center West, San Francisco
 |
 |
User Comments (0)
RSS Feeds